Effect of berberine on visceral hypersensitivity in a rat model of irritable bowel syndrome

World Chinese Journal of Digestology

Volumn 22, Issue 30, 2014, Pages 4566-4572

  Tang, Qing Lin ^a   Zhong, Yuan Fu ^a   Huang, Dong ^a   Li, Shi Dan ^a   He, Shao Hui ^a   Su, Jun Kai ^a   Zhang, Ming Qing ^a  

^a Orthopaedic Center of People s Liberation Army   (China)

Author keywords

Berberine; Irritable bowel syndrome; Visceral hypersensitivity

Indexed keywords

BERBERINE; INTERLEUKIN 6; PINAVERIUM; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEFECATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMOBILIZATION STRESS; IRRITABLE COLON; NONHUMAN; RAT; SCORING SYSTEM; VISCERAL HYPERSENSITIVITY; VISCERAL PAIN; WITHDRAWAL REFLEX;

EID: 84910109521     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v22.i30.4566     Document Type: Article

References (28)

1. Ford AC, Quigley EM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM, Moayyedi P. Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis. Am J Gastroenterol 2014; 109: 1547-1561 [PMID: 25070051 DOI: 10.1038/ajg.2014.202]
2. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130: 1377-1390 [PMID: 16678553 DOI: 10.1053/j.gastro.2006.03.008]
3. Tjong Y, Ip S, Lao L, Fong HH, Sung JJ, Berman B, Che C. Analgesic effect of Coptis chinensis rhizomes (Coptidis Rhizoma) extract on rat model of irritable bowel syndrome. J Ethnopharmacol 2011; 135: 754-761 [PMID: 21511022 DOI: 10.1016/ j.jep.2011.04.007]
4. Dai C, Guandalini S, Zhao DH, Jiang M. Antinociceptive effect of VSL#3 on visceral hypersensitivity in a rat model of irritable bowel syndrome: a possible action through nitric oxide pathway and enhance barrier function. Mol Cell Biochem 2012; 362: 43-53 [PMID: 22020749 DOI: 10.1007/ s11010-011-1126-5]
5. Dong YY, Chen FX, Yu YB, Du C, Qi QQ, Liu H, Li YQ. A school-based study with Rome III criteria on the prevalence of functional gastrointestinal disorders in Chinese college and university students. PLoS One 2013; 8: e54183 [PMID: 23349820 DOI: 10.1371/journal.pone.0054183]
6. van Wanrooij SJ, Wouters MM, Van Oudenhove L, Vanbrabant W, Mondelaers S, Kollmann P, Kreutz F, Schemann M, Boeckxstaens GE. Sensitivity testing in irritable bowel syndrome with rectal capsaicin stimulations: role of TRPV1 upregulation and sensitization in visceral hypersensitivity? Am J Gastroenterol 2014; 109: 99-109 [PMID: 24189713 DOI: 10.1038/ajg.2013.371]
7. Zhou Q, Verne GN. New insights into visceral hypersensitivity--clinical implications in IBS. Nat Rev Gastroenterol Hepatol 2011; 8: 349-355 [PMID: 21643039 DOI: 10.1038/nrgastro.2011.83]
8. van den Wijngaard RM, Stanisor OI, van Diest SA, Welting O, Wouters MM, de Jonge WJ, Boeckxstaens GE. Peripheral α-helical CRF (9-41) does not reverse stress-induced mast cell dependent visceral hypersensitivity in maternally separated rats. Neurogastroenterol Motil 2012; 24: 274-82, e111 [PMID: 22129370]
9. Asai M, Iwata N, Yoshikawa A, Aizaki Y, Ishiura S, Saido TC, Maruyama K. Berberine alters the processing of Alzheimer's amyloid precursor protein to decrease Abeta secretion. Biochem Biophys Res Commun 2007; 352: 498-502 [PMID: 17125739 DOI: 10.1016/j.bbrc.2006.11.043]
10. Domitrović R, Jakovac H, Blagojević G. Hepatoprotective activity of berberine is mediated by inhibition of TNF-α, COX-2, and iNOS expression in CCl(4)-intoxicated mice. Toxicology 2011; 280: 33-43 [PMID: 21095217 DOI: 10.1016/j.tox.2010.11.005]
11. Wang Y, Campbell T, Perry B, Beaurepaire C, Qin L. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats. Metabolism 2011; 60: 298-305 [PMID: 20304443 DOI: 10.1016/j.metabol.2010.02.005]
12. Sun Y, Xun K, Wang Y, Chen X. A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs 2009; 20: 757-769 [PMID: 19704371 DOI: 10.1097/CAD.0b013e328330d95b]
13. Diogo CV, Machado NG, Barbosa IA, Serafim TL, Burgeiro A, Oliveira PJ. Berberine as a promising safe anti-cancer agent - is there a role for mitochondria? Curr Drug Targets 2011; 12: 850-859 [PMID: 21269266]
14. Cai Y, Xia Q, Luo R, Huang P, Sun Y, Shi Y, Jiang W. Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo. J Nat Med 2014; 68: 53-62 [PMID: 23604974]
15. Grasberger H, Chang L, Shih W, Presson AP, Sayuk GS, Newberry RD, Karagiannides I, Pothoulakis C, Mayer E, Merchant JL. Identification of a functional TPH1 polymorphism associated with irritable bowel syndrome bowel habit subtypes. Am J Gastroenterol 2013; 108: 1766-1774 [PMID: 24060757 DOI: 10.1038/ajg.2013.304]
16. Zhan DW, Sun JH, Luo KT, Xu LZ, Zhou JL, Pei LX, Chen L, Wu XL, Zhang JW, Zhang W, Jiao DY, Zhu L. [Effects and efficacy observation of acupuncture on serum 5-HT in patients with diarrhea-predominant irritable bowel syndrome]. Zhongguo Zhenjiu 2014; 34: 135-138 [PMID: 24796047]
17. Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, Neal KR. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000; 47: 804-811 [PMID: 11076879]
18. Bose M, Farthing MJ. Irritable bowel syndrome: new horizons in pathophysiology and treatment. Br J Surg 2001; 88: 1425-1426 [PMID: 11683735 DOI: 10.1046/j.0007-1323.2001.01870.x]
19. Yu Y, Wu S, Li J, Wang R, Xie X, Yu X, Pan J, Xu Y, Zheng L. The effect of curcumin on the braingut axis in rat model of irritable bowel syndrome: involvement of 5-HT-dependent signaling. Metab Brain Dis 2014 May 8. [Epub ahead of print][PMID: 24807589 DOI: 10.1007/s11011-014-9554-z]
20. Mulé JJ, McIntosh JK, Jablons DM, Rosenberg SA. Antitumor activity of recombinant interleukin 6 in mice. J Exp Med 1990; 171: 629-636 [PMID: 2307930]
21. Dinan TG, Clarke G, Quigley EM, Scott LV, Shanahan F, Cryan J, Cooney J, Keeling PW. Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors. Am J Gastroenterol 2008; 103: 2570-2576 [PMID: 18785949 DOI: 10.1111/ j.1572-0241.2008.01871.x]
22. O'Malley D, Quigley EM, Cryan JF, Dinan TG. Plasma from patients with irritable bowel syndrome excites rat submucosal neurons via IL-6 and CRF1 receptor dependent mechanisms. Gastroenterology 2011; 140: S835
23. Gu L, Li N, Li Q, Zhang Q, Wang C, Zhu W, Li J. The effect of berberine in vitro on tight junctions in human Caco-2 intestinal epithelial cells. Fitoterapia 2009; 80: 241-248 [PMID: 19243699 DOI: 10.1016/ j.fitote.2009.02.005]
24. Chen FL, Yang ZH, Liu Y, Li LX, Liang WC, Wang XC, Zhou WB, Yang YH, Hu RM. Berberine inhibits the expression of TNFalpha, MCP-1, and IL-6 in AcLDL-stimulated macrophages through PPARgamma pathway. Endocrine 2008; 33: 331-337 [PMID: 19034703 DOI: 10.1007/s12020-008-9089-3]
25. Kim S, Kim Y, Kim JE, Cho KH, Chung JH. Berberine inhibits TPA-induced MMP-9 and IL-6 expression in normal human keratinocytes. Phytomedicine 2008; 15: 340-347 [PMID: 17951041 DOI: 10.1016/ j.phymed.2007.09.011]
26. Peng WH, Wu CR, Chen CS, Chen CF, Leu ZC, Hsieh MT. Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: interaction with drugs acting at 5-HT receptors. Life Sci 2004; 75: 2451-2462 [PMID: 15350820 DOI: 10.1016/j.lfs.2004.04.032]
27. Yang J, Wang HD, Lu DX, Wang YP, Qi RB, Li J, Li F, Li CJ. Effects of neutral sulfate berberine on LPS-induced cardiomyocyte TNF-alpha secretion, abnormal calcium cycling, and cardiac dysfunction in rats. Acta Pharmacol Sin 2006; 27: 173-178 [PMID: 16412266 DOI: 10.1111/j.1745-7254.2006.00257.x]
28. Qi MY, Feng Y, Dai DZ, Li N, Cheng YS, Dai Y. CPU86017, a berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting antioxidant activity. Acta Pharmacol Sin 2010; 31: 165-174 [PMID: 20139899 DOI: 10.1038/ aps.2009.180]